Advertisement

Topics

BioVex Company Profile

19:39 EDT 20th September 2017 | BioPortfolio

BioVex is a three year old private biotech company that is developing a new class of potent vaccines principally to treat and prevent cancer. The Company is headquartered in Oxford, UK.

The Company has three technology platforms based on the manipulation of the herpes simplex type one virus. The Company has two vaccine platforms; OncoVEX and ImmunoVEX and a functional genomics platform for gene determination in the nervous system (NeuroVEX)



The Company’s lead product OncoVEX GM-CSF is to enter Phase I/II studies in early 2002 in breast cancer, head and neck cancer and malignant melanoma. OncoVEX GM-CSF is scheduled to be the first lytic HSV vector (that selectively destroys tumour cells) containing an immune stimulating molecule to move into clinical development. It has the potential to treat metastatic as well as local disease.



The Company’s ImmunoVEX vaccine platform stimulates a key class of immune policing (dendritic) cells. The Company’s lead product to treat malignant melanoma is expected to enter the clinic in the first quarter of 2003.



The Company also has a portfolio of vaccines to treat other cancers and chronic infectious diseases for which pre-clinical data sets are being assembled. These include products for lung cancer, prostate cancer, HSV/HPV and Hepatitis B.

Location

BioVex Ltd, 70 Milton Park, Abingdon
Oxon
Oxfordshire
OX14 4RX
United Kingdom

Contact

Phone: +44 (0)1235 441900
Fax: +44 (0)1235 441901
Email: gbeynon@biovex.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

BioVex Inc.

BioVex is a privately held biotechnology company based in Woburn, Mass. where it also has an operational launch grade manufacturing facility. The Company is developing a new class...

BioVex Inc

BioVex is a privately held biotechnology company based in Woburn, Mass. where it also has an operational launch grade manufacturing facility. The Company is developing a new class...

BioVex

BioVex is a three year old private biotech company that is developing a new class of potent vaccines principally to treat and prevent cancer. The Company is headquartered in Oxford, UK. The Company ha...

Ysios Capital

Ysios Capital is an independent venture capital firm providing private equity financing to early through late-stage human healthcare and biotechnology companies with special focus...

More Information about "BioVex" on BioPortfolio

We have published hundreds of BioVex news stories on BioPortfolio along with dozens of BioVex Clinical Trials and PubMed Articles about BioVex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioVex Companies in our database. You can also find out about relevant BioVex Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record